Global Psoriasis Annual Report 2024–2025

The Global Psoriasis Atlas (GPA) is the first-ever comprehensive epidemiological resource for psoriasis. It contains data on the number of psoriasis cases worldwide., The Atlas also looks in depth at the experiences and faces behind people living with psoriasis. Read the GPA’s latest report Annual Report to learn about their research, international collaborations, events and digital developments during year 2 of Phase III of the GPA programme.
 

In 2024 the Global Psoriasis Atlas:

• Continued to expand its global network of Regional and National Coordinators. GPA Regional and National Coordinators are a network of passionate experts committed to understanding the epidemiology and burden of psoriasis and facilitating access to the best care for people living with the disease worldwide. The Coordinators play key roles in helping advance the collaboration, data collection and impact of the GPA.
• Published multiple papers in high impact journals including the Development and evaluation of an online training tool to aid in the diagnosis of chronic plaque psoriasis (CPP) in the Journal of the European Academy of Dermatology and Venereology and Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020 published in the British Journal of Dermatology.
• Attended worldwide conferences and events to enhance global collaborations.

“IFPA, together with global member organizations, is honoured to collaborate with ILDS and IPC on the Global Psoriasis Atlas (GPA) project. The GPA provides essential data on the global burden of psoriasis, mapping disease prevalence and its impact on quality of life. This evidence supports IFPA’s advocacy mission to improve the lives of individuals with psoriatic disease. By leveraging this data, IFPA can drive global recognition and action, ensuring that the unmet needs of people living with psoriasis are acknowledged and addressed.”

Ingvar Ágúst Ingvarsson, President IFPA.